{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:04:22Z","timestamp":1784181862094,"version":"3.55.0"},"reference-count":182,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>The 2026 British Association for Sexual Health and HIV (BASHH) guidelines for the management of viral hepatitis are in line with current evidence and practice within the United Kingdom. We provide evidence-based recommendations for the prevention, diagnosis and initial management of viral hepatitis A, B, C and D. Key updates are detailed at the start of the article.<\/jats:p>","DOI":"10.1177\/09564624261440830","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:51:31Z","timestamp":1778583091000},"page":"939-968","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["British Association of Sexual Health and HIV guidelines on the management of viral hepatitis 2026"],"prefix":"10.1177","volume":"37","author":[{"given":"Lucy","family":"Garvey","sequence":"first","affiliation":[{"name":"Department of HIV\/GU Medicine, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhagani","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and HIV Medicine, Royal Free London NHS Foundation Trust, London, UK"},{"name":"Division of Infection and Immunity, UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjababu","family":"Kulasegaram","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, Guys and St Thomas NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0197-458X","authenticated-orcid":false,"given":"Michael","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hathorn","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Randell","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, University Hospital Sussex NHS Trust, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9192-5268","authenticated-orcid":false,"given":"Ryan","family":"Whyte","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, Chelsea and Westminster NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Halford","sequence":"additional","affiliation":[{"name":"The Hepatitis C Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, Guys and St Thomas NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Villa","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, St James Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subathira","family":"Dakshina","sequence":"additional","affiliation":[{"name":"Department of HIV\/GU Medicine, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Mandal","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"e_1_3_4_4_2","unstructured":"British Association for Sexual Health and HIV (BASHH). 2017 interim update of the 2015 BASHH National Guidelines for the Management of the Viral Hepatitides. https:\/\/www.bashh.org\/_userfiles\/pages\/files\/resources\/viral_hepatitides_2017_update_181217.pdf (2017 accessed 28 January 2025)."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418767576"},{"issue":"4","key":"e_1_3_4_6_2","first-page":"1","article-title":"British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013","volume":"14","author":"Wilkins E","year":"2013","unstructured":"Wilkins E, Nelson M, Agarwal K, et al. British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013. HIV Med 2013; 14(Suppl 4): 1\u201371. https:\/\/doi.org\/10.1111\/hiv.12106","journal-title":"HIV Med"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1111\/hiv.12424","article-title":"British HIV Association Guidelines on the use of vaccines in HIV-positive adults 2015","volume":"17","author":"Geretti AM","year":"2016","unstructured":"Geretti AM, Brook G, Cameron C, et al. British HIV Association Guidelines on the use of vaccines in HIV-positive adults 2015. HIV Med 2016; 17 Suppl 3: s2\u2013s81. https:\/\/doi.org\/10.1111\/hiv.12424","journal-title":"HIV Med"},{"key":"e_1_3_4_10_2","unstructured":"UK Health Security Agency. Immunisation against infectious disease: the green book. https:\/\/www.gov.uk\/government\/collections\/immunisation-against-infectious-disease-the-green-book (2013 updated 15 October 2024 accessed 27 January 2025)."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00124-8"},{"key":"e_1_3_4_12_2","unstructured":"UK Health Security Agency. Hepatitis B: the green book chapter 18. Hepatitis B immunisation information for public health professionals. https:\/\/www.gov.uk\/government\/publications\/hepatitis-b-the-green-book-chapter-18 (2013 updated 14 August 2024 accessed 27 January 2025)."},{"key":"e_1_3_4_13_2","unstructured":"British HIV Association (BHIVA). British HIV Association guidelines on the use of vaccines in HIV-positive adults 2015 2015. https:\/\/bhiva.org\/wp-content\/uploads\/2024\/10\/2015-Vaccination-Guidelines.pdf"},{"key":"e_1_3_4_14_2","unstructured":"UK Health Security Agency. Hepatitis A: the green book chapter 17. Hepatitis A immunisation information for public health professionals. https:\/\/www.gov.uk\/government\/publications\/hepatitis-a-the-green-book-chapter-17 (2013 updated 15 January 2024 accessed 27 January 2025)."},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1258\/095646207782193902"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2022-055634"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13468"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815002605"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.008"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2012.0100"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.012"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2006.04.004"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6905a1"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.08.044"},{"key":"e_1_3_4_25_2","unstructured":"UK Health Security Agency. Public health control and management of hepatitis A - 2024 updated guidance. https:\/\/assets.publishing.service.gov.uk\/media\/65ccdbbd1d93950012946677\/Hepatitis-A-guidance-13-february-2024.pdf (2024 accessed 27 January 2025)."},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.74.2.110"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(90)93288-4"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.2.295"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(77)80090-5"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.75.5.340"},{"key":"e_1_3_4_31_2","first-page":"1656","article-title":"Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome","volume":"22","author":"Wu JC","year":"1995","unstructured":"Wu JC, Chen CM, Sheen IJ, et al. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 1995; 22: 1656\u20131660.","journal-title":"Hepatology"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00590.x"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01739311"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01407.x"},{"key":"e_1_3_4_35_2","first-page":"137","article-title":"Outbreak of hepatitis B in an acupuncture clinic","volume":"2","author":"Walsh B","year":"1999","unstructured":"Walsh B, Maguire H, Carrington D. Outbreak of hepatitis B in an acupuncture clinic. Commun Dis Public Health 1999; 2: 137\u2013140.","journal-title":"Commun Dis Public Health"},{"key":"e_1_3_4_36_2","unstructured":"Centers for Disease Control and Prevention (CDC) Haber P Schillie S. Epidemiology and prevention of vaccine-preventable diseases. Chapter 10: Hepatitis B. https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-10-hepatitis-b.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/hepb.html (09 May 2024 accessed 27 January 2025)."},{"key":"e_1_3_4_37_2","unstructured":"National Institute for Health and Care Excellence (NICE). Hepatitis B and C testing: people at risk of infection. Public health guideline [PH43]. https:\/\/www.nice.org.uk\/guidance\/ph43\/chapter\/Recommendations#recommendation-2-awareness-raising-for-people-at-increased-risk-of-hepatitis-b-or-c-infection (2012 updated 01 March 2013 accessed 28 January 2025)."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.12.009"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.08.074"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.6.2.133"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.4.5742"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy210.1940"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad201"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa439.066"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.10.023"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00012-2"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.11.057"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1086\/433180"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701522975"},{"key":"e_1_3_4_50_2","unstructured":"UK Health Security Agency. Human hepatitis B specific immunoglobulin for hepatitis B post-exposure prophylaxis. https:\/\/www.gov.uk\/government\/publications\/immunoglobulin-when-to-use\/hepatitis-b-immunoglobulin-issued-march-2021 (updated 7 November 2024 accessed 07 January 2025)."},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20816"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcfm.2006.02.018"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70237-2"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2006.00106.x"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-42929"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2007.04.012"},{"key":"e_1_3_4_57_2","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults","volume":"55","author":"Mast EE","year":"2006","unstructured":"Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55: 1\u201333; quiz CE31-34.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_4_58_2","unstructured":"Public Health England. Laboratory reports of hepatitis A infections in England and Wales 2019. https:\/\/assets.publishing.service.gov.uk\/media\/608c22e38fa8f51b9988cc42\/hpr0715_HAV19_v2.pdf (2021 accessed 27 January 2025)."},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268805005625"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.2807\/ese.18.11.20426-en"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21052"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2009.33.10"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-008-0633-0"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80371-X"},{"key":"e_1_3_4_65_2","unstructured":"National Institute for Health and Care Excellence (NICE). Clinical Knowledge summary: hepatitis A - risk factors. https:\/\/cks.nice.org.uk\/topics\/hepatitis-a\/background-information\/risk-factors\/ (2025 accessed 27 January 2025)."},{"key":"e_1_3_4_66_2","first-page":"163","article-title":"An outbreak of hepatitis A among young men associated with having sex in public venues","volume":"4","author":"Bell A","year":"2001","unstructured":"Bell A, Ncube F, Hansell A, et al. An outbreak of hepatitis A among young men associated with having sex in public venues. Commun Dis Public Health 2001; 4: 163\u2013170.","journal-title":"Commun Dis Public Health"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1086\/374057"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.028696"},{"key":"e_1_3_4_69_2","first-page":"43","article-title":"Outbreak of hepatitis A in Rotterdam associated with visits to 'darkrooms' in gay bars","volume":"2","author":"Reintjes R","year":"1999","unstructured":"Reintjes R, Bosman A, de Zwart O, et al. Outbreak of hepatitis A in Rotterdam associated with visits to 'darkrooms' in gay bars. Commun Dis Public Health 1999; 2: 43\u201346.","journal-title":"Commun Dis Public Health"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20781"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.2807\/ese.14.47.19421-en"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181812cdf"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.78.3.174"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1177\/1545109710385692"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1086\/338152"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy328"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21207"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00461-2"},{"key":"e_1_3_4_79_2","article-title":"Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention","author":"Lemon SM","year":"2017","unstructured":"Lemon SM, Ott JJ, Van Damme P, et al. Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol 2017, Online ahead of print. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.034","journal-title":"J Hepatol"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268801006185"},{"key":"e_1_3_4_81_2","first-page":"148","article-title":"Hepatitis A outbreak among adults with developmental disabilities in group homes -Michigan, 2013","volume":"64","author":"Bohm SR","year":"2015","unstructured":"Bohm SR, Berger KW, Hackert PB, et al. Hepatitis A outbreak among adults with developmental disabilities in group homes -Michigan, 2013. MMWR Morb Mortal Wkly Rep 2015; 64: 148\u2013152.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.37.1900670"},{"key":"e_1_3_4_83_2","unstructured":"European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: hepatitis A outbreak in the EU\/EEA mostly affecting men who have sex with men. https:\/\/www.ecdc.europa.eu\/en\/news-events\/epidemiological-update-hepatitis-outbreak-eueea-mostly-affecting-men-who-have-sex-men (updated 29 September 2017 accessed 29 January 2025)."},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-4470-3.50043-4"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1159\/000252779"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)32019-8"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.01.007"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1517\/17530059.2.3.303"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835df262"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.003"},{"key":"e_1_3_4_91_2","unstructured":"UK Health Security Agency. Hepatitis A immunoglobulin (issued 2024). https:\/\/www.gov.uk\/government\/publications\/immunoglobulin-when-to-use\/hepatitis-a-immunoglobulin-issued-2024 (updated 7 November 2024 accessed 27 January 2025)."},{"key":"e_1_3_4_92_2","unstructured":"World Health Organisation. Global hepatitis report 2024: action for access in low- and middle-income countries. https:\/\/www.who.int\/publications\/i\/item\/9789240091672 (2024 accessed 28 January 2025)."},{"key":"e_1_3_4_93_2","unstructured":"World Health Organisation. Hepatitis B fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b (2024 accessed 28 January 2025)."},{"key":"e_1_3_4_94_2","unstructured":"European Centre for Disease Prevention and Control (ECDC). ECDC evidence brief: prevention of hepatitis B and C in the EU\/EEA. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/prevention-hepatitis-b-and-c-eueea-2024 (2024 accessed 27 January 2025)."},{"key":"e_1_3_4_95_2","unstructured":"UK Health Security Agency. Hepatitis B in England - 2024. https:\/\/www.gov.uk\/government\/publications\/hepatitis-b-in-england\/hepatitis-b-in-england-2024 (2025 updated 06 January 2025 accessed 27 January 2025)."},{"key":"e_1_3_4_96_2","unstructured":"UK Health Security Agency. Acute hepatitis B: national enhanced surveillance report January to December 2022. https:\/\/www.gov.uk\/government\/publications\/acute-hepatitis-b-england-enhanced-surveillance-reports\/acute-hepatitis-b-national-enhanced-surveillance-report-january-to-december-2022 (updated 24 January 2024 accessed 08 January 2025)."},{"key":"e_1_3_4_97_2","unstructured":"UK Health Security Agency. Public health evaluation of BBV opt-out testing in EDs in England: 24-month interim report. https:\/\/www.gov.uk\/government\/publications\/bloodborne-viruses-opt-out-testing-in-emergency-departments\/public-health-evaluation-of-bbv-opt-out-testing-in-eds-in-england-24-month-interim-report (updated 28 November 2024 accessed 27 January 2025)."},{"key":"e_1_3_4_98_2","unstructured":"Centers for Disease Control and Prevention (CDC). Clinical testing and diagnosis for Hepatitis B. https:\/\/www.cdc.gov\/hepatitis-b\/hcp\/diagnosis-testing\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/hepatitis\/hbv\/testingchronic.htm (06 March 2024 accessed 27 January 2025)."},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/6.9.655"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-239"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1177\/014107689608900712"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1080\/13668250601146761"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.4.992"},{"key":"e_1_3_4_104_2","unstructured":"National Institute for Health and Care Excellence (NICE). Hepatitis B (chronic): diagnosis and management. Clinical guideline [CG165]. https:\/\/www.nice.org.uk\/guidance\/cg165 (2013 updated 20 October 2017 accessed 28 January 2025)."},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00895.x"},{"issue":"1","key":"e_1_3_4_106_2","first-page":"S41","article-title":"Partner notification for sexually transmitted diseases: an overview of the evidence","volume":"85","author":"Oxman AD","year":"1994","unstructured":"Oxman AD, Scott EA, Sellors JW, et al. Partner notification for sexually transmitted diseases: an overview of the evidence. Can J Public Health 1994; 85(Suppl 1): S41\u2013S47.","journal-title":"Can J Public Health"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462412472804"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008687"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001646"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00201-1"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.034"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1086\/503840"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.11.011"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.meg.0000243881.09820.09"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70264-5"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008023230510"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.07.017"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11913-1"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2023.03.001"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001632"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7201a1"},{"key":"e_1_3_4_123_2","unstructured":"National Institute for Health and Care Excellence (NICE). Clinical knowledge summary: hepatitis B - how to test for hepatitis B. https:\/\/cks.nice.org.uk\/topics\/hepatitis-b\/diagnosis\/how-to-test-for-hepatitis-b\/#:\u223c:text=Initialtestingshouldideallyinclude requireddependingonthefindings (2022 accessed 27 January 2025)."},{"key":"e_1_3_4_124_2","unstructured":"The Royal College of Pathologists. UK standards for microbiology investigations. https:\/\/www.rcpath.org\/profession\/publications\/standards-for-microbiology-investigations.html (accessed 29 January 2025)."},{"key":"e_1_3_4_125_2","unstructured":"ABC. https:\/\/www.rcpath.org\/static\/7875b72a-521a-4755-88ae270a2e230bf7\/cbe174cd-5788-49bb-8499d47428cbb441\/uk-smi-v-4i6-1-investigation-of-hepatitis-b-infection-july-2021-pdf.pdf"},{"key":"e_1_3_4_126_2","unstructured":"Public Health England. Hepatitis B factsheet. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2014\/11\/hepatitis-b-fctsht.pdf (2014 accessed 29 January 2025)."},{"key":"e_1_3_4_127_2","unstructured":"British Liver Trust. Hepatitis B: breaking the silence. https:\/\/britishlivertrust.org.uk\/hepatitis-b-breaking-the-silence\/?gad_source=1&gclid=EAIaIQobChMIh4X0wv_WiQMVw6NQBh1s7iVPEAAYASAAEgK6BPD_BwE (2014 accessed 29 January 2025)."},{"key":"e_1_3_4_128_2","unstructured":"World Health Organisation. Guidelines for the prevention diagnosis care and treatment for people with chronic hepatitis B infection. https:\/\/www.who.int\/publications\/i\/item\/9789240090903 (2024 accessed 03 February 2025)."},{"key":"e_1_3_4_129_2","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1111\/hiv.12718","article-title":"BHIVA\/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018","volume":"20","author":"Brady M","year":"2019","unstructured":"Brady M, Rodger A, Asboe D, et al. BHIVA\/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. HIV Med 2019; 20 Suppl 2: s2\u2013s80. https:\/\/doi.org\/10.1111\/hiv.12718","journal-title":"HIV Med"},{"key":"e_1_3_4_130_2","unstructured":"British Viral Hepatitis Group (BVHG) and Maternal and Paediatric Subgroup. Guideline for the management of hepatitis B in pregnancy and the exposed infant. https:\/\/www.basl.org.uk\/uploads\/BVHGPerinatalHBV3.3.21.pdf (2021 accessed 29 January 2025)."},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-871194"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.035"},{"key":"e_1_3_4_133_2","unstructured":"British HIV Association (BHIVA). UK guideline for the use of HIV Post-exposure prophylaxis following sexual exposure (PEPSE) 2015 2015. https:\/\/www.bhiva.org\/file\/6074031a87755\/PEPSE-guidelines.pdf"},{"key":"e_1_3_4_134_2","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goz023"},{"key":"e_1_3_4_135_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323888"},{"key":"e_1_3_4_136_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323628"},{"key":"e_1_3_4_137_2","unstructured":"National Institute for Health and Care Excellence (NICE). Bulevirtide for treating chronic hepatitis D. Technology appraisal guidance [TA896]. https:\/\/www.nice.org.uk\/guidance\/ta896\/evidence (2023 accessed 28 January 2025)."},{"key":"e_1_3_4_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00472-6"},{"key":"e_1_3_4_139_2","unstructured":"UK Health Security Agency. Hepatitis C in UK 2023: working to eliminate hepatitis C as a public health threat. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1133731\/hepatitis-c-in-the-UK-2023.pdf (2023 accessed 08 January 2025)."},{"key":"e_1_3_4_140_2","unstructured":"World Health Organisation. Global health sector strategy on viral hepatitis 2016\u20132021: towards ending viral hepatitis 2016. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06"},{"key":"e_1_3_4_141_2","unstructured":"World Health Organisation. Global health sector strategies on respectively HIV viral hepatitis and sexually transmitted infections for the period 2022-2030 2022. https:\/\/iris.who.int\/bitstream\/handle\/10665\/360348\/9789240053779-eng.pdf?sequence=1"},{"key":"e_1_3_4_142_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz076"},{"key":"e_1_3_4_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30249-2"},{"key":"e_1_3_4_144_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04150.x"},{"key":"e_1_3_4_145_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26164"},{"key":"e_1_3_4_146_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.2.160"},{"key":"e_1_3_4_147_2","doi-asserted-by":"publisher","DOI":"10.1086\/516785"},{"key":"e_1_3_4_148_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02165.x"},{"key":"e_1_3_4_149_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23808"},{"key":"e_1_3_4_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30303-4"},{"key":"e_1_3_4_151_2","doi-asserted-by":"publisher","DOI":"10.1086\/518796"},{"key":"e_1_3_4_152_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2003.008532"},{"key":"e_1_3_4_153_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3281053a0c"},{"key":"e_1_3_4_154_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051542"},{"key":"e_1_3_4_155_2","doi-asserted-by":"publisher","DOI":"10.1086\/509922"},{"key":"e_1_3_4_156_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002622"},{"key":"e_1_3_4_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00077-7"},{"key":"e_1_3_4_158_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa021"},{"key":"e_1_3_4_159_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1007"},{"key":"e_1_3_4_160_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac273"},{"key":"e_1_3_4_161_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13297"},{"key":"e_1_3_4_162_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13286"},{"key":"e_1_3_4_163_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac270"},{"key":"e_1_3_4_164_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu447"},{"key":"e_1_3_4_165_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403173301103"},{"key":"e_1_3_4_166_2","doi-asserted-by":"publisher","DOI":"10.1086\/497701"},{"key":"e_1_3_4_167_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200111000-00011"},{"key":"e_1_3_4_168_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21023"},{"key":"e_1_3_4_169_2","unstructured":"Hepatitis B or C infections and breastfeeding | breastfeeding special circumstances | CDC (accessed 2 March 2026)."},{"key":"e_1_3_4_170_2","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdaa022"},{"key":"e_1_3_4_171_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360713"},{"key":"e_1_3_4_172_2","unstructured":"Public Health England. Evaluation of hepatitis C test and treat interventions targeted at homeless populations (outside London) in England during the COVID-19 pandemic. 2020 Report 2021. https:\/\/assets.publishing.service.gov.uk\/media\/5ffc9a85e90e07639fd8d4b9\/Evaluation_of_initiatives_to_test_and_treat_the_housed_homeless_2020_report.pdf"},{"key":"e_1_3_4_173_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01688.x"},{"key":"e_1_3_4_174_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001507"},{"key":"e_1_3_4_175_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200103000-00006"},{"key":"e_1_3_4_176_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800051293"},{"key":"e_1_3_4_177_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1807-5"},{"key":"e_1_3_4_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.007"},{"key":"e_1_3_4_179_2","unstructured":"National Institute for Health and Care Excellence (NICE). Clinical knowledge summary: who should I test for hepatitis C? https:\/\/cks.nice.org.uk\/topics\/hepatitis-c\/diagnosis\/who-to-screen-test\/ (2022 accessed 27 January 2025)."},{"key":"e_1_3_4_180_2","unstructured":"Public Health England. Hepatitis C: guidance on the investigation and management of occupational exposure. https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/+\/. https:\/\/www.hpa.org.uk\/cdph\/issues\/CDPHVol2\/no4\/guides_hepC.pdf (1999 accessed 03 February 2025)."},{"key":"e_1_3_4_181_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32831940a3"},{"key":"e_1_3_4_182_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw252"},{"key":"e_1_3_4_183_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0065"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624261440830","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09564624261440830","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624261440830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:08:56Z","timestamp":1784178536000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09564624261440830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":182,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/09564624261440830"],"URL":"https:\/\/doi.org\/10.1177\/09564624261440830","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}